Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (41-50 of 211) with videos related to

Pageof 22
Sort By:
Cancer Chemotherapy Reports|February 1, 1972
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumorsP Dombernowsky, N I Nissen, V Larsen
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lungH S Jensen, H H Hansen, P Dombernowsky
Seminars in Oncology|September 5, 1998
Gemcitabine and paclitaxel combinations in non-small cell lung cancerP Dombernowsky, G Giaccone, A Sandler, et al.
International Journal of Oncology|May 17, 2011
Bone-marrow hemosiderin iron and serum iron status markers in small-cell carcinoma of the lungN Milman, A Mellemgaard, S Hansen, et al.
Seminars in Oncology|September 1, 1978
Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinomaH H Hansen, P Dombernowsky, F R Hirsch
Cancer Treatment Reports|November 1, 1985
Skeletal muscle biopsies in patients treated with doxorubicinH Havsteen, I Brynjolf, B Hainau, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 1, 1993
The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancerC Kamby, C Egsmose, G Söletormos, et al.
Lancet (London, England)|March 22, 1975
Letter: Treatment of small-cell carcinoma of bronchusF M Muggia, H H Hansen, P Dombernowsky
Anticancer Research|January 1, 1994
Treatment of small cell lung cancer: the Copenhagen experienceF R Hirsch, P Dombernowsky, H H Hansen
Ugeskrift for Laeger|January 27, 2000
[Herceptin (trastuzumab). A new exciting therapeutic principle in breast cancer]S V Holm-Hansen, C Kamby, P Dombernowsky
Pageof 22

Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Cancer Chemotherapy Reports|February 1, 1972
Clinical investigation of a new podophyllum derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidene- -D-glucopyranoside) (NSC-122819), in patients with malignant lymphomas and solid tumorsP Dombernowsky, N I Nissen, V Larsen
Cancer Chemotherapy and Pharmacology|January 1, 1980
Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lungH S Jensen, H H Hansen, P Dombernowsky
Seminars in Oncology|September 5, 1998
Gemcitabine and paclitaxel combinations in non-small cell lung cancerP Dombernowsky, G Giaccone, A Sandler, et al.
International Journal of Oncology|May 17, 2011
Bone-marrow hemosiderin iron and serum iron status markers in small-cell carcinoma of the lungN Milman, A Mellemgaard, S Hansen, et al.
Seminars in Oncology|September 1, 1978
Staging procedures and prognostic features in small cell anaplastic bronchogenic carcinomaH H Hansen, P Dombernowsky, F R Hirsch
Cancer Treatment Reports|November 1, 1985
Skeletal muscle biopsies in patients treated with doxorubicinH Havsteen, I Brynjolf, B Hainau, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|August 1, 1993
The diagnostic and prognostic value of serum bone Gla protein (osteocalcin) in patients with recurrent breast cancerC Kamby, C Egsmose, G Söletormos, et al.
Lancet (London, England)|March 22, 1975
Letter: Treatment of small-cell carcinoma of bronchusF M Muggia, H H Hansen, P Dombernowsky
Anticancer Research|January 1, 1994
Treatment of small cell lung cancer: the Copenhagen experienceF R Hirsch, P Dombernowsky, H H Hansen
Ugeskrift for Laeger|January 27, 2000
[Herceptin (trastuzumab). A new exciting therapeutic principle in breast cancer]S V Holm-Hansen, C Kamby, P Dombernowsky
Pageof 22